Careers  |  Sign In  |  Register

Latest in Medical Students

Reuters Health • The Doctor's Channel Daily Newscast

Novel Therapy Effective Against T-Cell Lymphoma

NEW YORK (Reuters Health) - Patients who have undergone prior systemic therapies for cutaneous T-cell lymphoma may respond well to treatment with romidepsin, a potent inhibitor of histone deacetylases, according to the results of a multicenter, open-label phase II study. Dr. Sean Whittaker of St. Thomas...

Reuters Health • The Doctor's Channel Daily Newscast

Protease Inhibitor Amplifies HCV Therapy

NEW YORK (Reuters Health) – The response rate with standard treatment of hepatitis C infection is doubled when a hepatitis C virus (HCV) protease inhibitor, boceprevir, is added to the regimen, a multicenter team reports in an online issue of The Lancet released August 9. “Standard-of-care treatment...

Reuters Health • The Doctor's Channel Daily Newscast

Earlier Incubator-Crib Transfer Safe for Preemies

NEW YORK (Reuters Health) – Babies born at a gestational age of 30-35 weeks can be safely transferred from the incubator to an open crib once they reach 1600 grams weight. This early weaning in turn leads to early discharge home, Italian physicians report in the September issue of...